** Shares of derivatives exchange operator CME Group CME.O rise as much as 4.9%, last up 3.9% at $251.05
** CME reports Q4 adjusted profit of $2.52/shr, beating Wall Street expectations of $2.44/shr, according to estimates compiled by LSEG
** Uncertainty around the U.S. election and economy, as well as geopolitics in the reported quarter, drove up demand for CME's hedging products
** "With volume growth across every asset class, we hit new records in interest rates, including U.S. Treasury and SOFR complexes, as well as in agricultural, foreign exchange and metals markets," CEO Terry Duffy says
** Q4 clearing and transaction fees, CME's major chunk of revenue, rose 4% to $1.23 billion
** Raymond James says better pricing in interest rate and equity index futures drove the Q4 beat
** CME stock rose 10.3% in 2024
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.